GenAI drug discovery firm Insilico raises $123m as it eyes Hong Kong IPO

GenAI drug discovery firm Insilico raises $123m as it eyes Hong Kong IPO

Photo by Braňo on Unsplash

16 June, 2025

Edited by: Pramod Mathew

Alex Zhavoronkov drug discovery Generative AI Hong Kong IPO Insilico Medicine Value Partners Group Warburg Pincus

Printed by Unregistered user on Thu, 30 Oct 2025 22:46:06 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Venture Capital

Sanofi, Cathay Capital set up $275m fund to back clinical-stage innovative drugs in China

VCs remain bullish on China’s deeptech despite LLM bubble bursting

Read more from Greater China

China Digest: Ardian opens HK office; Lightspeed China rebrands to Luminous Ventures

Boyu Capital races ahead to buy stake in Starbucks China